the Australia question that gets asked weekly, answered properly
Long-ish post, sorry. tl;dr at the bottom.
I have been tracking PBS against ApoB for 3 weeks because I could not find anyone who had. The correlation is weaker than I expected, which is itself mildly interesting given how confidently people link the two in here.
Caveats up front: one person, one lab, one assay, no control, and I changed my training in the middle of it, which was stupid.
tl;dr: probably real, definitely smaller than the threads imply, and not worth reorganising your week around.
best — the order this archive was captured in
Mechanistically the bit that matters is shortage. It explains most of the early profile and a decent chunk of the outcome.
Rodent data is rodent data. Dose scaling is not linear and the models tell you what to investigate, not what to expect.
Week 7 for me and the honest summary is: 25kg down, muscle cramps manageable, and I have thought about food maybe four times today.
My version of this: I was so worried about the injection that I put it off for eleven days. The injection is the easiest part.
Ireland here. Waited 3 months on a list, gave up, went private, and the total cost was roughly what I expected.
TGA shortage notices are temporary
Disagree. What you are describing is consistent with shortage, not with what you concluded.
My version of this: I was so worried about the injection that I put it off for eleven days. The injection is the easiest part.
the regulatory PBS is the blocker
Stalled for 21 weeks, changed nothing, and it started moving again on week 27.
unfunded-means-full-price is the NZ reality
Strongly agree. AU and NZ differ.
New Zealand is different on the two sides
Strongly agree. AU and NZ differ.
- 1Week 7 for me and the honest summary is: 25kg down, muscle cramps…6 comments in this branch · started by u/sarcopenia_watch
- 2the regulatory PBS is the blocker6 comments in this branch · started by u/aussie_pbs_watch